Till Wenger

2.1k total citations · 1 hit paper
24 papers, 1.5k citations indexed

About

Till Wenger is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Till Wenger has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Genetics. Recurrent topics in Till Wenger's work include RNA Interference and Gene Delivery (7 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Virus-based gene therapy research (4 papers). Till Wenger is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Virus-based gene therapy research (4 papers). Till Wenger collaborates with scholars based in Germany, France and United States. Till Wenger's co-authors include Tobias L. Haas, Henning Walczak, Ingrid Herr, Christoph H. Emmerich, Eva Rieser, Björn Gerlach, James E. Vince, Uwe Warnken, Ronald Koschny and Stefanie M. Cordier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Blood.

In The Last Decade

Till Wenger

24 papers receiving 1.5k citations

Hit Papers

Recruitment of the Linear Ubiquitin Chain Assembly Comple... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Till Wenger Germany 19 1.0k 576 334 278 197 24 1.5k
Andris Avots Germany 21 1.0k 1.0× 913 1.6× 328 1.0× 285 1.0× 147 0.7× 36 1.8k
Yvan Martineau France 22 1.5k 1.5× 353 0.6× 230 0.7× 381 1.4× 149 0.8× 33 2.0k
Anna Zachariou United Kingdom 13 1.5k 1.5× 483 0.8× 194 0.6× 265 1.0× 299 1.5× 17 1.8k
Jean Lozach United States 14 1.2k 1.2× 531 0.9× 322 1.0× 277 1.0× 126 0.6× 15 1.9k
Bryan C. Barnhart United States 21 1.4k 1.4× 839 1.5× 373 1.1× 431 1.6× 203 1.0× 34 2.1k
Sergei Chuvpilo Germany 21 1.1k 1.1× 865 1.5× 449 1.3× 311 1.1× 73 0.4× 31 1.8k
Mike Hupe Germany 10 1.0k 1.0× 562 1.0× 247 0.7× 171 0.6× 171 0.9× 10 1.3k
Victoria C. Pham United States 20 1.5k 1.5× 511 0.9× 279 0.8× 388 1.4× 338 1.7× 35 1.9k
Elisabeth Kowenz‐Leutz Germany 20 1.7k 1.7× 560 1.0× 318 1.0× 405 1.5× 151 0.8× 31 2.3k
Juliane Lüscher‐Firzlaff Germany 21 1.3k 1.3× 436 0.8× 204 0.6× 549 2.0× 170 0.9× 31 2.3k

Countries citing papers authored by Till Wenger

Since Specialization
Citations

This map shows the geographic impact of Till Wenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Till Wenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Till Wenger more than expected).

Fields of papers citing papers by Till Wenger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Till Wenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Till Wenger. The network helps show where Till Wenger may publish in the future.

Co-authorship network of co-authors of Till Wenger

This figure shows the co-authorship network connecting the top 25 collaborators of Till Wenger. A scholar is included among the top collaborators of Till Wenger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Till Wenger. Till Wenger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melcher, Michael, Norbert Auer, Friedrich Leisch, et al.. (2018). Changes in Chromosome Counts and Patterns in CHO Cell Lines upon Generation of Recombinant Cell Lines and Subcloning. Biotechnology Journal. 13(3). e1700495–e1700495. 42 indexed citations
3.
Strotbek, Michaela, et al.. (2017). ATF6β‐based fine‐tuning of the unfolded protein response enhances therapeutic antibody productivity of Chinese hamster ovary cells. Biotechnology and Bioengineering. 114(6). 1310–1318. 27 indexed citations
4.
Strotbek, Michaela, et al.. (2017). Secretory pathway optimization of CHO producer cells by co-engineering of the mitosRNA-1978 target genes CerS2 and Tbc1D20. Metabolic Engineering. 40. 69–79. 20 indexed citations
5.
Terawaki, Seigo, Voahirana Camosseto, Till Wenger, et al.. (2015). RUN and FYVE domain–containing protein 4 enhances autophagy and lysosome tethering in response to Interleukin-4. The Journal of Cell Biology. 210(7). 1133–1152. 51 indexed citations
6.
Wenger, Till, Jochen Schaub, Barbara Enenkel, et al.. (2013). BI-HEX®-GlymaxX® cells enable efficient production of next generation biomolecules with enhanced ADCC activity. BMC Proceedings. 7(S6). 3 indexed citations
7.
Clavarino, Giovanna, Thérèse Couderc, Alexandre Dalet, et al.. (2012). Induction of GADD34 Is Necessary for dsRNA-Dependent Interferon-β Production and Participates in the Control of Chikungunya Virus Infection. PLoS Pathogens. 8(5). e1002708–e1002708. 94 indexed citations
8.
Wenger, Till, Seigo Terawaki, Voahirana Camosseto, et al.. (2012). Autophagy inhibition promotes defective neosynthesized proteins storage in ALIS, and induces redirection toward proteasome processing and MHCI-restricted presentation. Autophagy. 8(3). 350–363. 54 indexed citations
9.
David, Alexandre, Aude De Gassart, Francesca Rigotti, et al.. (2011). BAD-LAMP is a novel biomarker of nonactivated human plasmacytoid dendritic cells. Blood. 118(3). 609–617. 26 indexed citations
10.
Haas, Tobias L., Christoph H. Emmerich, Björn Gerlach, et al.. (2009). Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction. Molecular Cell. 36(5). 831–844. 596 indexed citations breakdown →
11.
Zhang, Chengwen, Alexander Marmé, Till Wenger, et al.. (2006). Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas. International Journal of Oncology. 28(2). 551–8. 39 indexed citations
12.
Wenger, Till, J Mattern, Roland Penzel, et al.. (2006). Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors. Cell Death and Differentiation. 13(10). 1740–1751. 19 indexed citations
14.
Wenger, Till, J Mattern, Tobias L. Haas, et al.. (2006). Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects. Cancer Gene Therapy. 14(3). 316–326. 11 indexed citations
15.
Gast, Daniela, Svenja Riedle, Annette Schneider, et al.. (2005). L1 augments cell migration and tumor growth but not β3 integrin expression in ovarian carcinomas. International Journal of Cancer. 115(4). 658–665. 58 indexed citations
16.
Stoeck, Alexander, Yasmin Issa, Till Wenger, et al.. (2005). L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells. Cancer Letters. 239(2). 212–226. 41 indexed citations
17.
Kolb, Armin, J Mattern, Nikolaus Gaßler, et al.. (2005). Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy. Cancer Letters. 242(1). 104–111. 37 indexed citations
18.
Zuliani, Cecilia, Susanne Kleber, Till Wenger, et al.. (2005). Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death and Differentiation. 13(1). 31–40. 86 indexed citations
19.
Gaßler, Nikolaus, Till Wenger, Hendrik Dienemann, et al.. (2005). Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo. British Journal of Cancer. 92(6). 1084–1088. 40 indexed citations
20.
Mattern, J, et al.. (2003). Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells. British Journal of Cancer. 89(11). 2155–2162. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026